20-6085084-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_017671.5(FERMT1):c.1575A>G(p.Lys525=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.385 in 1,611,858 control chromosomes in the GnomAD database, including 123,102 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.41 ( 13259 hom., cov: 32)
Exomes 𝑓: 0.38 ( 109843 hom. )
Consequence
FERMT1
NM_017671.5 synonymous
NM_017671.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.13
Genes affected
FERMT1 (HGNC:15889): (FERM domain containing kindlin 1) This gene encodes a member of the fermitin family, and contains a FERM domain and a pleckstrin homology domain. The encoded protein is involved in integrin signaling and linkage of the actin cytoskeleton to the extracellular matrix. Mutations in this gene have been linked to Kindler syndrome. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 20-6085084-T-C is Benign according to our data. Variant chr20-6085084-T-C is described in ClinVar as [Benign]. Clinvar id is 260866.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-6085084-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.621 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FERMT1 | NM_017671.5 | c.1575A>G | p.Lys525= | synonymous_variant | 12/15 | ENST00000217289.9 | |
FERMT1 | XM_024451935.2 | c.1575A>G | p.Lys525= | synonymous_variant | 12/15 | ||
FERMT1 | XM_047440259.1 | c.1575A>G | p.Lys525= | synonymous_variant | 12/15 | ||
FERMT1 | XM_047440260.1 | c.1290A>G | p.Lys430= | synonymous_variant | 11/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FERMT1 | ENST00000217289.9 | c.1575A>G | p.Lys525= | synonymous_variant | 12/15 | 1 | NM_017671.5 | P1 | |
FERMT1 | ENST00000478194.1 | n.535A>G | non_coding_transcript_exon_variant | 4/7 | 1 | ||||
FERMT1 | ENST00000536936.1 | c.*1077A>G | 3_prime_UTR_variant, NMD_transcript_variant | 11/14 | 1 | ||||
FERMT1 | ENST00000699095.1 | c.1575A>G | p.Lys525= | synonymous_variant | 11/14 | P1 |
Frequencies
GnomAD3 genomes AF: 0.412 AC: 62447AN: 151568Hom.: 13241 Cov.: 32
GnomAD3 genomes
AF:
AC:
62447
AN:
151568
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.404 AC: 101621AN: 251396Hom.: 21746 AF XY: 0.395 AC XY: 53602AN XY: 135862
GnomAD3 exomes
AF:
AC:
101621
AN:
251396
Hom.:
AF XY:
AC XY:
53602
AN XY:
135862
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.383 AC: 558652AN: 1460172Hom.: 109843 Cov.: 36 AF XY: 0.381 AC XY: 276750AN XY: 726506
GnomAD4 exome
AF:
AC:
558652
AN:
1460172
Hom.:
Cov.:
36
AF XY:
AC XY:
276750
AN XY:
726506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.412 AC: 62506AN: 151686Hom.: 13259 Cov.: 32 AF XY: 0.410 AC XY: 30396AN XY: 74110
GnomAD4 genome
AF:
AC:
62506
AN:
151686
Hom.:
Cov.:
32
AF XY:
AC XY:
30396
AN XY:
74110
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1695
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 74% of patients studied by a panel of primary immunodeficiencies. Number of patients: 65. Only high quality variants are reported. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Kindler syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at